Diff Diag of parkinson's Disease, Multiple Sys Atrophy, & Steele-Richardson-Olszewski Syndrome:Striatal F-Dopa PET Data
JNNP 57:278-284, Burn,D.J.,et al, 1994
Striatal D2 Receptor Status in Patients with Parkinson's Disease, Striatonigral Degeneration, and PSP, (PET)
Ann Neurol 31:184-192, Brooks,D.J.,et al, 1992
Positron Emission Tomography in Progressive Supranuclear Palsy
Arch Neurol 48:389-391, Bhatt,M.H.,et al, 1991
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Cerebral Hypometabolism in Progressive Supranuclear Palsy Studied with Positron Emission Tomography
Ann Neurol 24:399-406, Foster,N.L.,et al, 1988
Progressive Supranuclear Palsy & a Multi-Infarct State
Neurol 37:570-576, Dubinsky,R.M.&Jankovic,J., 1987
CT Findings in Progressive Supranuclear Palsy
J Comput Assist Tomogr 8:406-409, Ambrosetto,P.,et al, 1984
Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983
Progressive Supranuclear Palsy, Computed Tomography, & Response to Antiparkinsonian Drugs
Neurol 31:442-445, Haldeman,S.,et al, 1981
Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy
JAMA Neurol 77:1569, Park, J.E., 2020
Zolpidem in Progressive Supranuclear Palsy
NEJM 341:543-544, Daniele,A.,et al, 1999
Pharmacological Therapy in Progressie Supranuclear Palsy
Arch Neurol 55:1099-1102, Kompoliti,K.,et al, 1998
Parkinsonism-Recognition and Differential Diagnosis
BMJ 310:447-452, Quinn,N., 1995